A rapid visual immunoassay for qualitative detection of Influenza A and B antigens using colloidal gold technology. Provides presumptive results for respiratory infection screening.
Manufactured by
China
Hangzhou Lysun Biotechnology Co., Ltd. is a biomedical company specializing in in-vitro diagnostic reagents and medical instruments, established in 2018. The company holds EN ISO 13485:2016 certification and CE marking, with over 20 patents. Lysun focuses on POCT products for self-testing, clinical biochemistry, and immunology, including COVID-19 antibody and antigen detection kits approved for export to multiple countries.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Hangzhou Frenovo Biotech Co., Ltd
China · 1 relevant product
Qingdao Hightop Biotech Co., Ltd
China · 2 relevant products
Anbio Biotechnology Limited
Germany · 1 relevant product
AccuBioTech Co., Ltd.
China · 1 relevant product
SureScreen Diagnostics Limited
United Kingdom · 3 relevant products
VEDALAB SAS
France · 1 relevant product
Operon S.A.
Spain · 3 relevant products
GenSure Biotech Inc.
China · 2 relevant products
GENOMER BİYOTEKNOLOJİ ARGE SAN. VE TİC.
Türkiye · 2 relevant products
Guangzhou Labsim Medical Diagnostics Co., Ltd.
China · 1 relevant product
64 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →8 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 114 closest product alternatives
Hangzhou Frenovo Biotech Co., Ltd · China
Rapid immunoassay for simultaneous detection of influenza A and B antigens. Provides quick diagnosis of seasonal influenza infection.
Qingdao Hightop Biotech Co., Ltd · China
Rapid antigen test for simultaneous detection of SARS-CoV-2 and Influenza A+B from respiratory specimens. Delivers results within 15-20 minutes, enabling quick triage and differential diagnosis in clinical and point-of-care settings. Colloidal gold immunochromatographic technology provides high sensitivity and specificity for acute respiratory infection management.
Anbio Biotechnology Limited · Germany
Rapid immunochromatographic assay for simultaneous detection of influenza A and B viral antigens. Provides point-of-care results for acute respiratory illness diagnosis.
AccuBioTech Co., Ltd. · China
Rapid immunoassay for simultaneous detection of influenza A and B viruses. Enables quick differentiation of influenza strains in acute respiratory illness cases.
SureScreen Diagnostics Limited · United Kingdom
A rapid antigen test for simultaneous detection of Influenza A and B viruses. Provides quick differentiation between influenza types for appropriate patient management. Results available within minutes for clinical decision-making.
VEDALAB SAS · France
Immunochromatographic rapid test for qualitative detection of influenza A and B viruses in nasal swab samples. Facilitates rapid diagnosis during influenza surveillance and clinical assessment.
Operon S.A. · Spain
A rapid diagnostic test for the simultaneous detection of Influenza A and B viruses in human samples. Used for in vitro diagnosis of respiratory infections.
GenSure Biotech Inc. · China
Rapid antigen detection test kit for simultaneous identification of Influenza A and B viruses from respiratory specimens. Delivers results within minutes using immunochromatographic technology, enabling point-of-care diagnosis in clinical and home settings. NMPA-approved for accurate respiratory pathogen screening.
GENOMER BİYOTEKNOLOJİ ARGE SAN. VE TİC. · Türkiye
Rapid immunochromatographic test kit for qualitative detection of Influenza A and B antigens in respiratory specimens. Delivers results within 10-15 minutes, enabling prompt clinical decision-making and infection control measures in acute care settings. Single-use format with integrated sample processing and visual readout.
Guangzhou Labsim Medical Diagnostics Co., Ltd. · China
Rapid immunochromatographic test kit for simultaneous detection of Influenza A and B virus antigens in respiratory specimens. Delivers results within 10-15 minutes, enabling quick clinical decision-making in point-of-care settings. Suitable for emergency departments, urgent care clinics, and routine screening during flu seasons.
Bioantibody Biotechnology Co., Ltd. · China
Rapid immunoassay test for detection of influenza A and B viruses. Enables quick identification of influenza infection.
Lumigenex (Suzhou) Co., Ltd · China
A rapid test kit for detecting both SARS-CoV-2 and Influenza A+B antigens in patient samples using colloidal gold immunochromatographic technology. The kit provides qualitative results for simultaneous COVID-19 and influenza diagnosis.
102 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products